Burden of varicella in Central and Eastern Europe: findings from a systematic literature review

References

• European Centre for Disease Prevention and Control. ECDC guidance: varicella vaccination in the European Union. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf
   Google Scholar
• Riera-Montes M, Bollaerts K, Heininger U, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17:353.
   PubMed Web of Science ®Google Scholar
• Meszner Z, Molnar Z, Rampakakis E, et al. Economic burden of varicella in children 1-12 years of age in Hungary, 2011-2015. BMC Infect Dis. 2017;17:495.
   PubMed Web of Science ®Google Scholar
• Gabutti G, Franchi M, Maniscalco L, et al. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs. Minerva Pediatr. 2016;68:213–225.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Breuer J, Gershon A, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26.
   PubMed Web of Science ®Google Scholar
• Helmuth IG, Poulsen A, Suppli CH, et al. Varicella in Europe - a review of the epidemiology and experience with vaccination. Vaccine. 2015;33:2406–2413.
   PubMed Web of Science ®Google Scholar
• Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2:39–55.
   PubMedGoogle Scholar
• European centre for disease prevention and control. Vaccination scheduler. 2018. Available from: https://ecdc.europa.eu/en/immunisation-vaccines/EU-vaccination-schedules
   Google Scholar
• ThePharmaLetter. Hungary to provide chickenpox vaccine free of charge from next January. [cited]. Available from: https://www.thepharmaletter.com/article/hungary-to-provide-chickenpox-vaccine-free-of-charge-from-next-january
   Google Scholar
• Brisson M, Gay NJ, Edmunds WJ, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500–2507.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PloS One. 2013;8:e66485.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Den Bergh J, Meysman P, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. 2017;7:1077.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Willem L, Beutels P, et al. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. eLife. 2015;4:e07116.
   Web of Science ®Google Scholar
• Guzzetta G, Poletti P, Merler S, et al. The epidemiology of herpes zoster after varicella immunization under different biological hypotheses: perspectives from mathematical modeling. Am J Epidemiol. 2016;183:765–773.
   PubMed Web of Science ®Google Scholar
• Betta M, Laurino M, Pugliese A, et al. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proc Biol Sci. 2016;283:20160054.
   PubMed Web of Science ®Google Scholar
• Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination – the global experience. Expert Rev Vaccines. 2017;16:833–843.
   PubMed Web of Science ®Google Scholar
• Robo A. Varicella outbreaks in Albania. Acta Microbiol Hellenica. 2015;60:158.
   Google Scholar
• Siennicka J, Trzcinska A, Rosinska M, et al. Seroprevalence of varicella-zoster virus in Polish population. Przegl Epidemiol. 2009;63:495–499.
   PubMedGoogle Scholar
• Socan M, Berginc N. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students. Wien Klin Wochenschr. 2008;120:422–426.
   PubMed Web of Science ®Google Scholar
• Sočan M, Berginc N, Lajovic J. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health. 2010;10:360.
   PubMed Web of Science ®Google Scholar
• Vilibic-Cavlek T, Ljubin-Sternak S, Kolaric B, et al. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing. Arch Gynecol Obstet. 2012;286:901–904.
   PubMed Web of Science ®Google Scholar
• Arama V. Varicella in Romania: epidemiological trends, 1986-2004. Euro Surveill. 2005;10:E050811–E050816.
   PubMedGoogle Scholar
• Bakasun V, Pahor D. Epidemiological patterns of varicella in the period of 1977 to 2012 in the Rijeka district, Croatia. Epidemiol Res Int. 2014. Volume 2014, Article ID 193678, 4 pages. Available from: http://dx.doi.org/10.1155/2014/193678.
   PubMedGoogle Scholar
• EUVAC.net. Varicella surveillance report 2010. Available from: https://ecdc.europa.eu/en/publications-data/varicella-surveillance-report-2010
   Google Scholar
• Gowin E, Wysocki J, Michalak M. Don’t forget how severe varicella can be–complications of varicella in children in a defined Polish population. Int J Infect Dis. 2013;17:e485–e489.
   PubMed Web of Science ®Google Scholar
• Hoxha H. The study of epidemiological data of varicella and its complications in Albanian children. Int J Infect Dis. 2010;14:e464.
   Web of Science ®Google Scholar
• Lipke M, Paradowska-Stankiewicz I. Chickenpox in Poland in 2011. Przegl Epidemiol. 2013;67:195–197, 317–198.
   Google Scholar
• Sočan M, Blaško M. Surveillance of varicella and herpes zoster in Slovenia, 1996–2005. Euro Surveill. 2007;12:687.
   Google Scholar
• Socan M, Kraigher A, Pahor L. Epidemiology of varicella in Slovenia over a 20-year period (1979-98). Epidemiol Infect. 2001;126:279–283.
   PubMed Web of Science ®Google Scholar
• Komitova R, Boev I, Kazakova Z, et al. Varicella complications-could we do more? Arch Dis Childhood. 2014;99:A308.
   Google Scholar
• Kuchar E, Miskiewicz K, Szenborn L, et al. Respiratory complications in children hospitalized with varicella. Adv Exp Med Biol. 2013;788:97–102.
   PubMed Web of Science ®Google Scholar
• Mijailovic Z, Canovic P, Todorovic Z, et al. Characteristics of radiological changes in lungs during varicella zoster viral infection. Med Glas (Zenica). 2011;8:280–283.
   PubMedGoogle Scholar
• VENICE-II Consortium. Varicella and herpes zoster: surveillance and vaccination recommendations 2010-2011. Available from: http://venice.cineca.org/report_final_varicella.pdf
   Google Scholar
• Croatian National Institute of Public Health. Croatian health service yearbook 2013. Available from: https://www.hzjz.hr/wp-content/uploads/2014/12/Ljetopis_2013__.pdf
   Google Scholar
• Socan M. Evaluation of mandatory case-based reporting system for varicella in the prevaccine era. Cent Eur J Public Health. 2010;18:99–103.
   PubMedGoogle Scholar
• Bollaerts K, Riera-Montes M, Heininger U, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145:2666–2677.
   PubMed Web of Science ®Google Scholar
• Infekcijas slimības un imunizācija. Slimibu profilakses un kontroles centrs. [Infectious diseases and immunization. Hospital profile and control center]. Available from: https://www.spkc.gov.lv/lv/statistika-un-petijumi/infekcijas-slimibas/valsts-statistikas-parskati/statistikas-parskati Latvian.
   Google Scholar
• National Center of Public Health and Analyses in Bulgaria. Registered cases of certain infectious disease subject to obligatory reporting. Available from: http://ncpha.government.bg/files/nczi/zdr.statistika/health_BB_1.pdf
   Google Scholar
• Savickiene E, Caplinskas S, Skrickiene A, et al. Epidemiological situation of varicella (chickenpox) in Lithuania. Poster session presented at: 14th Congress of the BADV. 2nd Vilnius Summit on Communicable Diseases; 2017 Oct 4 –7;Vilnius, Lithuania.
   Google Scholar
• Sergamumo Užkrečiamosiomis Ligomis Lietuvoje 2016 M. Apžvalga [Incidence of infectious diseases in Lithuania in 2016: overview]. Available from: http://www.ulac.lt/uploads/downloads/en_sergamumo_katalogas/2016_en/Sergamumo_apzvalga_2016.pdf Lithuanian.
   Google Scholar
• Epidemiološko Spremljanje Nalezljivih Bolezni v Sloveniji v Letu 2016. [Epidemiological monitoring of common diseases in Slovenia in 2016]. [cited Nov 2018]. Available from: http://www.nijz.si/sites/www.nijz.si/files/datoteke/epidemiolosko_spremljanje_nb_slo_2016.pdf Slovenian.
   Google Scholar
• Leonid I, Evelyn L. Primary varicella in an immunocompetent adult. J Clin Aesthet Dermatol. 2009;2:36–38.
   PubMedGoogle Scholar
• Ahčan J, Čižman M, Pleterski-Rigler D, et al. [Varicella hospitalization]. Zdrav Vestn. 2002;71: 621–627. Slovenian.
   Google Scholar
• Wolfson L, Giglio N, Castilo M. The use of antibiotics in the treatment of pediatric varicella patients: evidence from the multi-country MARVEL study. Int J Infect Dis. 2018;73S:139.
   Google Scholar
• Toth E. Varicella, a cost of illness Hungarian study. Value Health. 2012;15:A390.
   Web of Science ®Google Scholar
• Hudeckova H, Straka S, Rusnakova S. Epidemiological features and economic evaluation of a potential chickenpox vaccination strategy in Slovak Republic. Cent Eur J Public Health. 2000;8:227–228.
   PubMedGoogle Scholar
• Ahčan J, Čižman M, Pleterski-Rigler D, et al. [Value of universal childhood varicella vaccination in Slovenia]. Zdrav Vestn. 2002;71: 667–672. Slovenian.
   Google Scholar
• Wysocki J, Malecka I, Stryczynska-Kazubska J, et al. Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015. BMC Public Health. 2018;18:410.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Systematic review of available evidence on effectiveness and duration of protection of varicella vaccines. Available from: http://www.who.int/immunization/sage/meetings/2014/april/4_Systematic_review_on_effectiveness_and_duration_of_protection_of_varicella_vaccines.pdf
   Google Scholar
• Maltezou HC, Wicker S, Borg M, et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 2011;29:9557–9562.
   PubMed Web of Science ®Google Scholar
• Szabo LJ, Jackowska T, KaloZ, et al. Varicella vaccination in Hungary and Poland: optimization of public benefits from prophylaxis technologies in the time of austerity. New Med. 2013;3:97–102.
   Google Scholar
• Richter D, Anca I, Andre FE, et al. Immunization of high-risk paediatric populations: central European vaccination awareness group recommendations. Expert Rev Vaccines. 2014;13:801–815.
   PubMed Web of Science ®Google Scholar
• Allaert FA, Blanc A, Megard Y, et al. Parents’ attitudes towards varicella vaccination acceptance in France and Germany: effect of vaccine recommendation and reimbursement (a survey). J Public Health. 2009;17:71–76.
   Google Scholar
• Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132–137.
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28:686–691.
   PubMed Web of Science ®Google Scholar
• Thomas CA, Shwe T, Bixler D, et al. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J. 2014;33:1164–1168.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Lopez AS, Watson TL, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011;128:1071–1077.
   PubMed Web of Science ®Google Scholar